Bayesian Health
Bayesian Health is a pioneering startup in the healthcare industry, offering an adaptive AI/ML platform that forecasts declining trajectories within a hospital or health system’s patient population. Its groundbreaking approach, referred to as Intelligent Care Augmentation, empowers clinicians with real-time care signals to manage outcomes and costs. The platform is designed to identify and intervene with next-best actions in a timely way, sending accurate and actionable clinical signals for various critical condition areas within the EMR and existing workflows.
The company's mission to catch life-threatening complications much earlier leads to better patient outcomes and reductions in healthcare costs. Founded in 2016 and headquartered in the United States, Bayesian Health recently secured a $15.00M Venture Round investment on 12 July 2021, with participation from esteemed investors like Andreessen Horowitz/a16z, Catalio Capital Management, Health2047 Capital Partners, and LifeForce Capital.
With its commitment to enabling optimal decision-making for care teams using AI/ML techniques, Bayesian Health is set to revolutionize healthcare delivery by providing clinicians with the best data and inferences. Learn more at bayesianhealth.com.
No recent news or press coverage available for Bayesian Health.